<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36820">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02627196</url>
  </required_header>
  <id_info>
    <org_study_id>360043-001</org_study_id>
    <nct_id>NCT02627196</nct_id>
  </id_info>
  <brief_title>Barostim Therapy for Heart Failure</brief_title>
  <acronym>BeAT-HF</acronym>
  <official_title>Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CVRx, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CVRx, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to develop valid scientific evidence for safety and
      effectiveness of Baroreflex Activation Therapy® with the BAROSTIM NEO® System in subjects
      with heart failure, defined as New York Heart Association (NYHA) functional class III and
      left ventricular ejection fraction (LVEF) ≤ 35% despite being treated with the appropriate
      heart failure guideline directed therapy, excluding subjects eligible for or actively
      receiving Cardiac Resynchronization Therapy (CRT).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
    <masking_description>Open Label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Cardiovascular Mortality and Heart Failure Morbidity</measure>
    <time_frame>At study completion, approximately 5 years</time_frame>
    <description>To demonstrate that treatment with the BAROSTIM NEO® System, relative to medical management, reduces the rate of cardiovascular mortality or worsening heart failure that leads to hospitalization, cardiac assist device or heart transplant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Neurological and Cardiovascular Events (MANCE)</measure>
    <time_frame>6 months post implant</time_frame>
    <description>To demonstrate the safety of the Barostim NEO® System via the event-free rate of all system- and procedure-related Major Adverse Neurological and Cardiovascular Events (MANCE) occurring within 6 months post implant in the device arm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amino-terminal prohormone of brain natriuretic peptide (NT-proBNP)</measure>
    <time_frame>6 months post implant</time_frame>
    <description>To demonstrate that treatment with the BAROSTIM NEO® system results in a larger reduction in NT-proBNP at 6 months than medical management.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six Minute Hall Walk (6MHW)</measure>
    <time_frame>6 months post implant.</time_frame>
    <description>To demonstrate that treatment with the BAROSTIM NEO® system results in a larger improvement in 6MHW at 6 months than medical management</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Minnesota Living With Heart Failure Quality of Life (MLWHF QOL)</measure>
    <time_frame>6 months post implant</time_frame>
    <description>To demonstrate that treatment with the BAROSTIM NEO® System results in a larger improvement in MLWHF QOL at 6 months than medical management</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Device Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive Barostim Activation Therapy® with the implanted BAROSTIM NEO® System in addition to optimal guideline directed medical management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Guideline Directed Medical Management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be followed under optimal guideline directed medical management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BAROSTIM NEO® System</intervention_name>
    <arm_group_label>Device Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Currently NYHA Class II or III heart failure.

          2. Left ventricular ejection fraction ≤ 35% within 45 days prior to randomization.

          3. Heart failure accompanied by a BNP or NT-proBNP greater than or equal to a predefined
             BNP/NT-proBNP eligibility value within 45 days prior to randomization. BNP/NT-proBNP
             eligibility values are adjusted based on each subject's Body Mass Index (BMI), heart
             failure history, and atrial fibrillation history.

          4. On optimal, stable, Guideline Directed Medical Therapy (GDMT) per country specific
             guidelines for the treatment of heart-failure throughout screening/baseline
             evaluation and for at least 4 weeks prior to obtaining any post-consent screening
             parameters.

          5. Six-minute hall walk (6MHW) ≥ 150m AND ≤ 400m within 45 days prior to randomization.

          6. The artery planned for the BAROSTIM implant must have:

               -  At least one carotid bifurcation as identification by a bilateral carotid duplex
                  ultrasound within 6 months prior to randomization that is:

                    -  Below the level of the mandible

                    -  Has no ulcerative carotid arterial plaques

                    -  Has no carotid atherosclerosis producing at 50% or greater reduction in
                       linear diameter of the internal carotid

                    -  Has no carotid atherosclerosis producing at 50% or greater reduction in
                       linear diameter of the distal common carotid

               -  No prior surgery, radiation, or endovascular stent placement in the carotid
                  artery or the carotid sinus region.

          7. If female and of childbearing potential, must use a medically accepted method of
             birth control and have a negative pregnancy test within 14 days of randomization.

          8. Received a standard cardiac work up and is an appropriate candidate for the study and
             the surgical procedure as determine by a trial cardiologist and trial surgeon.

          9. Subjects implanted with a cardiac rhythm management device that does not utilize an
             intracardiac lead, or implanted with a neurostimulation device, must be approved
             prior to enrollment.

         10. Signed a CVRx-approved informed consent form for participation in this trial.

        Exclusion Criteria:

          1. Received cardiac resynchronization therapy (CRT) within 6 months of randomization, or
             is actively receiving CRT.

          2. Currently have a Class I indication for a cardiac resynchronization therapy (CRT)
             device according to the American Heart Association/American College of
             Cardiology/European Society of Cardiology (AHA/ACC/ESC) guidelines for the treatment
             of congestive heart failure.

          3. Known or suspected baroreflex failure or autonomic neuropathy.

          4. AHA/ACC Stage D heart failure within 45 days prior to randomization.

          5. BMI &gt; 40.

          6. Serum estimated glomerular filtration rate (eGFR) &lt; 25 mL/min/173m^2 within 45 days
             prior to randomization.

          7. Recurring resting heart rate of either &lt; 60 beats per minute(bpm) or &gt; 100 bpm via
             clinic measurements within 45 days prior to randomization. (Heart rate of &lt; 60bpm is
             not applicable to subjects with an implanted device capable of pacing).

          8. Recurring symptomatic hypotension within 45 days prior to randomization.

          9. Significant uncontrolled symptomatic bradyarrhythmias or unstable ventricular
             arrhythmias.

         10. Subjects with any surgery that has occurred, or is planned to occur, within 45 days
             of the BAROSTIM NEO® implant procedure.

         11. Episode of NYHA class IV heart failure with acute pulmonary edema within 45 days
             prior to randomization.

         12. Any of the following within 3 months of randomization:

               -  Myocardial infarction

               -  Unstable angina

               -  Percutaneous coronary intervention

               -  Cerebral vascular accident or transient ischemic attack

               -  Sudden cardiac death

         13. Solid organ or hematologic transplant, or currently being actively evaluated for an
             organ transplant.

         14. Has received or is receiving left ventricular assist device (LVAD) therapy.

         15. Has received or is receiving chronic dialysis.

         16. Heart failure secondary to a reversible cause, such as cardiac structural valvular
             disease, acute myocarditis and pericardial constriction.

         17. Primary pulmonary hypertension.

         18. Infiltrative cardiomyopathy.

         19. Severe chronic obstructive pulmonary disease (COPD) or severe restrictive lung
             disease.

         20. Active malignancy.

         21. Current or planned treatment with intravenous positive inotrope therapy

         22. Life expectancy less than one year.

         23. Clinically significant psychological condition that, in the physician's opinion,
             would prohibit the subject's ability to meet the protocol requirements.

         24. Unable or unwilling to fulfill the protocol medication compliance, testing, and
             follow-up requirements.

         25. Enrolled and active in another clinical trial (unless previously approved by the CVRx
             Clinical Department).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Heart and Rhythm Solutions, PLLC</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85286</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Court</last_name>
      <phone>480-289-4550</phone>
      <email>hcourt@heartrs.com</email>
    </contact>
    <investigator>
      <last_name>Himal Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Heart Rhythm Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Raymond</last_name>
      <phone>602-456-2342</phone>
      <email>sraymond@azheartrhythm.com</email>
    </contact>
    <investigator>
      <last_name>Vijay Swarup</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Cardiovascular Research Group</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Foughi</last_name>
      <phone>480-818-0492</phone>
      <email>hfoughi@insightmedr.com</email>
    </contact>
    <investigator>
      <last_name>Marwan Bahu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Regional Medical Center</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Craff</last_name>
      <phone>479-463-7856</phone>
      <email>mcraff@wregional.com</email>
    </contact>
    <investigator>
      <last_name>Joel Carver</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Muir Health Clinical Research Center</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Trachuk</last_name>
      <phone>925-674-2580</phone>
      <email>rita.trachuk@johnmuirhealth.com</email>
    </contact>
    <investigator>
      <last_name>Ryan Brown</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glendale Adventist Medical Center</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Valeriano</last_name>
      <phone>818-409-8009</phone>
      <email>valerij1@ah.org</email>
    </contact>
    <investigator>
      <last_name>John McKenzie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Health Services</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Deck</last_name>
      <phone>949-680-3490</phone>
      <email>jdeck@researchalliance.com</email>
    </contact>
    <investigator>
      <last_name>Kenneth Deck</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Los Alamitos Cardiovascular</name>
      <address>
        <city>Los Alamitos</city>
        <state>California</state>
        <zip>90720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haniah Blanton</last_name>
      <phone>562-430-7533</phone>
      <phone_ext>292</phone_ext>
      <email>hblanton@losalcardio.com</email>
    </contact>
    <investigator>
      <last_name>Steven Forman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern California Permanente Medical Group</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Gilfillan</last_name>
      <phone>323-783-7387</phone>
      <email>kimberly.r.gilfillan@kp.org</email>
    </contact>
    <investigator>
      <last_name>Nigel Gupta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Sourthern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Minor</last_name>
      <phone>323-442-7983</phone>
      <email>melissa.minor@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Luanda Grazette</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Specialists</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Gremminger</last_name>
      <phone>650-962-4566</phone>
      <email>joyce_gremminger@elcaminohospital.org</email>
    </contact>
    <investigator>
      <last_name>Bing Liem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Price</last_name>
      <phone>949-764-4510</phone>
      <email>wendy.price@hoag.org</email>
    </contact>
    <investigator>
      <last_name>Rajesh Banker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dignity Health</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelley Allen</last_name>
      <phone>916-736-2626</phone>
      <email>shelley.allen@dignityhealth.org</email>
    </contact>
    <investigator>
      <last_name>Arash Aryana</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Chula Vista Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cary Murphy</last_name>
      <phone>858-939-7197</phone>
      <email>Cary.murphy@sharp.com</email>
    </contact>
    <investigator>
      <last_name>GilAnthony Ungab</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Westcott</last_name>
      <phone>415-502-0523</phone>
      <email>sarah.westcott@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Liviu Klein</last_name>
      <phone>415-476-2143</phone>
      <email>liviu.klein@ucsf.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Liviu Klein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bonometti, Inc</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Marks</last_name>
      <phone>805-845-6611</phone>
      <email>jaimemarks38@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Claudio Bonometti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centura Health-Penrose St. Francis Health Services</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawna Mistretta</last_name>
      <phone>719-776-4567</phone>
      <email>shawnamistretta@centura.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Cole</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Colorado Medical Center</name>
      <address>
        <city>Greeley</city>
        <state>Colorado</state>
        <zip>80631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Coombs</last_name>
      <phone>970-392-2012</phone>
      <email>ann.coombs@bannerhealth.com</email>
    </contact>
    <investigator>
      <last_name>Lin Wang Dong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center of the Rockies Research</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Turner</last_name>
      <phone>970-624-1684</phone>
      <email>sara.turner@uchealth.org</email>
    </contact>
    <investigator>
      <last_name>Patrick Green</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Marshall</last_name>
      <phone>202-741-2318</phone>
      <email>lmarshall@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Gurusher Panjrath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlantic Clinical Research Center - Cardiology</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mila Moreiras</last_name>
      <phone>561-966-8815</phone>
      <email>mmoreiras@acrcfl.com</email>
    </contact>
    <investigator>
      <last_name>Debra Weinstein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clearwater Cardiovascular Consultants</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Maloney</last_name>
      <phone>727-467-9393</phone>
      <phone_ext>209</phone_ext>
      <email>maloneyk@cccheart.com</email>
    </contact>
    <investigator>
      <last_name>Marilyn King</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Stastny</last_name>
      <phone>407-303-5600</phone>
      <phone_ext>1103439</phone_ext>
      <email>carol.stastny@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Nirav Raval</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Lee</last_name>
      <phone>813-394-5602</phone>
      <email>courtneyelee@tgh.org</email>
    </contact>
    <investigator>
      <last_name>Fadi Matar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercer University</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Damron</last_name>
      <phone>478-301-5813</phone>
      <email>damron_ml@mercer.edu</email>
    </contact>
    <investigator>
      <last_name>Jalal Ghali</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queens Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malia Young</last_name>
      <phone>808-691-8768</phone>
      <email>mayoung@queens.org</email>
    </contact>
    <investigator>
      <last_name>David Singh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Medical Group</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60540</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josilyn Klimek</last_name>
      <phone>630-785-2671</phone>
      <email>josilyn.klimek@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Maria Costanzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carle Foundation Hospital</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauryn Charles</last_name>
      <phone>217-383-6622</phone>
      <email>lauryn.charles@carle.com</email>
    </contact>
    <investigator>
      <last_name>Vimal Rabdiya</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Group - Deaconess</name>
      <address>
        <city>Newburgh</city>
        <state>Indiana</state>
        <zip>47630</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Johnson</last_name>
      <phone>812-490-4505</phone>
      <email>amanda.johnson@deaconess.com</email>
    </contact>
    <investigator>
      <last_name>Ashwani Bedi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie Dampier</last_name>
      <phone>859-323-1781</phone>
      <email>dampier@email.uky.edu</email>
    </contact>
    <investigator>
      <last_name>Sibu Saha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Bowers</last_name>
      <phone>504-988-2030</phone>
      <email>sbowers@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>Colleen Johnson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Davis</last_name>
      <phone>504-842-8476</phone>
      <email>sdavis@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Freddy Abi-Samra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Michaelian</last_name>
      <phone>617-789-3041</phone>
      <email>margaret.michaelian@steward.org</email>
    </contact>
    <investigator>
      <last_name>Lana Tsao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MidMichigan Medical Center - Midland</name>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <zip>48670</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Prior</last_name>
      <phone>989-631-2469</phone>
      <email>jamie.prior@midmichigan.org</email>
    </contact>
    <investigator>
      <last_name>Michael Lauer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Roseville</city>
        <state>Michigan</state>
        <zip>48066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Bess</last_name>
      <phone>313-343-4811</phone>
      <email>renee.bess@stjohn.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Davis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan CardioVascular Institute at Covenant Medical Center</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Bitzer</last_name>
      <phone>989-583-6372</phone>
      <email>vbitzer@mcvi.com</email>
    </contact>
    <investigator>
      <last_name>Peter Fattal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theresa Hickey</last_name>
      <phone>601-984-5678</phone>
      <email>tlhickey@umc.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Moore</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Research Springfeild</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherri Swafford</last_name>
      <phone>417-820-9587</phone>
      <email>sherri.swafford@mercy.net</email>
    </contact>
    <investigator>
      <last_name>Shang-Chuin Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Amsler</last_name>
      <phone>314-747-8542</phone>
      <email>jmamsler@dom.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Ewald</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Heart and Vascular</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Tindall</last_name>
      <phone>314-251-3932</phone>
      <email>crystal.tindall@mercy.net</email>
    </contact>
    <investigator>
      <last_name>Khaled Awad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bryan Heart</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Baehr</last_name>
      <phone>402-328-3939</phone>
      <email>dbaehr@neheart.com</email>
    </contact>
    <investigator>
      <last_name>Anuj Jain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center of Southern Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Bimbi</last_name>
      <phone>702-383-7302</phone>
      <email>robert.bimbi@umcsn.com</email>
    </contact>
    <investigator>
      <last_name>Chowdhury Ahsan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Healthcare Partners Clinical Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie Abano</last_name>
      <phone>702-933-9419</phone>
      <email>cabano@hcpnv.com</email>
    </contact>
    <investigator>
      <last_name>Dhiraj Narula</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung Center</name>
      <address>
        <city>Brown Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Scott</last_name>
      <phone>609-893-6611</phone>
      <phone_ext>5028</phone_ext>
      <email>scotte@deborah.org</email>
    </contact>
    <investigator>
      <last_name>Niya Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Tancredi</last_name>
      <phone>551-996-2353</phone>
      <email>jana.tancredi@hackensackmeridian.org</email>
    </contact>
    <investigator>
      <last_name>Robert Berkowitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14623</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Stuart</last_name>
      <phone>585-341-7764</phone>
      <email>robin_stuart@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>John Bisognano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital - Long Island</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanya Buchrieser</last_name>
      <phone>516-629-2090</phone>
      <email>tanya.buchrieser@chsli.org</email>
    </contact>
    <investigator>
      <last_name>Timothy Vittorio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David White</last_name>
      <phone>513-585-2198</phone>
      <email>david.white@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Thomas O'Brien</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Stockdale</last_name>
      <phone>614-292-4084</phone>
      <email>sarah.stockdale@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Rami Kahwash</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cardiovascular Research Group</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>India Williams</last_name>
      <phone>405-608-3800</phone>
      <phone_ext>1275</phone_ext>
      <email>iwilliams@okheart.com</email>
    </contact>
    <investigator>
      <last_name>Pamela Craven</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lancaster General Hospital</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kay Knepper</last_name>
      <phone>717-544-1777</phone>
      <email>kmkneppe@lghealth.org</email>
    </contact>
    <investigator>
      <last_name>Justin Roberts</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Drexel University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Matthews</last_name>
      <phone>215-762-8570</phone>
      <email>janet.matthews@drexelmed.edu</email>
    </contact>
    <investigator>
      <last_name>Howard Eisen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Bernardini</last_name>
      <phone>412-359-3281</phone>
      <email>sbernard@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>Srinivas Murali</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindsey Stewart</last_name>
      <phone>843-792-1238</phone>
      <email>stew@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Adrian Van Bakel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular Foundation</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Austin</last_name>
      <phone>901-271-4181</phone>
      <email>naust@sterncardio.com</email>
    </contact>
    <investigator>
      <last_name>Frank McGrew</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research Foundation</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantel Scallon</last_name>
      <phone>512-458-9410</phone>
      <email>cmscallon@austinheartbeat.com</email>
    </contact>
    <investigator>
      <last_name>Andrea Natale</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Research Institute of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiran Asma</last_name>
      <phone>214-360-0869</phone>
      <email>kasma@civadallas.com</email>
    </contact>
    <investigator>
      <last_name>Martin Berk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tyler Cardiovascular Consultants</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg Murphy</last_name>
      <phone>903-510-7291</phone>
      <email>gmurphy@etmc.org</email>
    </contact>
    <investigator>
      <last_name>Raul Torres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Heart Institute</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Bryan</last_name>
      <phone>801-507-4846</phone>
      <email>julia.bryan@imail.org</email>
    </contact>
    <investigator>
      <last_name>Rami Alharethi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Hanson</last_name>
      <phone>801-585-2490</phone>
      <email>heather.hanson@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Edward Gilbert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Mason</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Vogt</last_name>
      <phone>206-342-6514</phone>
      <email>suzanne.vogt@virgniamason.org</email>
    </contact>
    <investigator>
      <last_name>Robert Rho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aspirus Research Institute</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Johnson</last_name>
      <phone>715-847-2273</phone>
      <email>megan.johnson@aspirus.org</email>
    </contact>
    <investigator>
      <last_name>German Larrain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cvrx.com</url>
    <description>Sponsor Website</description>
  </link>
  <link>
    <url>https://www.beathf.com/</url>
    <description>Study Website</description>
  </link>
  <reference>
    <citation>Fu Q, Zhang R, Witkowski S, Arbab-Zadeh A, Prasad A, Okazaki K, Levine BD. Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity? Hypertension. 2005 Apr;45(4):513-21. Epub 2005 Feb 28.</citation>
    <PMID>15738344</PMID>
  </reference>
  <reference>
    <citation>Esler M, Kaye D. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst. 1998 Oct 15;72(2-3):210-9. Review.</citation>
    <PMID>9851571</PMID>
  </reference>
  <reference>
    <citation>Sleight P. The importance of the autonomic nervous system in health and disease. Aust N Z J Med. 1997 Aug;27(4):467-73. Review.</citation>
    <PMID>9448899</PMID>
  </reference>
  <reference>
    <citation>Peters TK, Koralewski HE, Zerbst E. Blood pressure and heart rate changes during physical activity upon heart rate feedback-controlled electrical carotid sinus nerve stimulation. Int J Cardiol. 1989 Mar;22(3):389-92.</citation>
    <PMID>2785088</PMID>
  </reference>
  <reference>
    <citation>Georgakopoulos D, Wagner D, Cates AW, Irwin E, Lovett EG. Effects of electrical stimulation of the carotid sinus baroreflex using the Rheos device on ventricular-vascular coupling and myocardial efficiency assessed by pressure-volume relations in non-vagotomized anesthetized dogs. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:2025-9. doi: 10.1109/IEMBS.2009.5334421.</citation>
    <PMID>19964769</PMID>
  </reference>
  <reference>
    <citation>Sabbah HN, Gupta RC, Imai M, Irwin ED, Rastogi S, Rossing MA, Kieval RS. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail. 2011 Jan;4(1):65-70. doi: 10.1161/CIRCHEARTFAILURE.110.955013. Epub 2010 Nov 19.</citation>
    <PMID>21097604</PMID>
  </reference>
  <reference>
    <citation>Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007 Nov;50(5):904-10. Epub 2007 Sep 10.</citation>
    <PMID>17846349</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 15, 2017</lastchanged_date>
  <firstreceived_date>December 7, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>BAROSTIM NEO®</keyword>
  <keyword>Baroreceptor</keyword>
  <keyword>Baroreflex</keyword>
  <keyword>Baroreflex Activation Therapy™</keyword>
  <keyword>New York Heart Associate Class III Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
